---
category: listing
circular_id: 8992c37daf430290
date: '2025-11-27'
description: Announcement of the listing and admission to dealings of equity shares
  of Sudeep Pharma Limited on BSE SME platform.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={3C5B5533-E7D9-4FD8-AADD-EA6ADD04996F}&noticeno=20251127-13&dt=11/27/2025&icount=13&totcount=16&flag=0
impact: low
impact_ranking: low
importance_ranking: medium
justification: New SME listing announcement with specific scrip details but pending
  listing date. Medium importance for traders interested in new SME listings, low
  market-wide impact.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251127-13&attachedId=
processing:
  attempts: 1
  content_hash: 3b0591693a9d983c
  processed_at: '2025-11-27T09:24:17.424976'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-11-27T08:32:50+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={3C5B5533-E7D9-4FD8-AADD-EA6ADD04996F}&noticeno=20251127-13&dt=11/27/2025&icount=13&totcount=16&flag=0
severity: low
source: bse
stocks:
- SUDEEPPHRM
tags:
- equity
- ipo
- listing
- sme
title: Listing of Equity Shares of Sudeep Pharma Limited
---

## Summary

BSE has announced that the equity shares of Sudeep Pharma Limited will be listed and admitted to dealings on the BSE SME platform. The company has been assigned scrip code 544619, symbol SUDEEPPHRM, and ISIN number INE0QPI01025. The exact listing date and additional security details will be communicated through a separate notice.

## Key Points

- Company Name: Sudeep Pharma Limited
- Scrip Code: 544619
- Trading Symbol: SUDEEPPHRM
- ISIN: INE0QPI01025
- Platform: BSE SME Segment
- Listing will occur in due course with date to be notified separately

## Regulatory Changes

No regulatory changes introduced. This is a standard new listing notification.

## Compliance Requirements

- Trading members should note the scrip details for future trading once listing date is announced
- No immediate action required until the listing date notice is issued

## Important Dates

- Notice Date: November 27, 2025
- Listing Date: To be notified through separate notice

## Impact Assessment

This announcement has limited immediate market impact as it is an informational notice about an upcoming SME listing. The actual listing date and price band details are pending. Trading members and investors interested in SME segment stocks should watch for the follow-up notice with specific listing date and security details. The impact is confined to the SME segment and relevant to investors seeking exposure to pharmaceutical sector SME companies.